Covered recipient · General Payments record
JOHN THOMAS HERION
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$1,360.97
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $551.95 | 24 |
| Consulting Fee | $425.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $605.57 | 9 |
| Acerta Pharma LLC | $136.66 | 4 |
| Amgen Inc. | $73.37 | 4 |
| Janssen Biotech, Inc. | $34.90 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $25.85 | 1 |
| Fresenius Kabi USA, LLC | $22.99 | 1 |
| GENZYME CORPORATION | $22.83 | 1 |
| UCB, Inc. | $20.04 | 1 |
| Lilly USA, LLC | $18.69 | 1 |
| Aurinia Pharma U.S., Inc. | $16.05 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201920222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.55 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103908374 | CMS |
| ABBVIE INC. | $83.48 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103908376 | CMS |
| ABBVIE INC. | $2.51 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103908378 | CMS |
| ABBVIE INC. | $4.15 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103908380 | CMS |
| ABBVIE INC. | $15.91 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103908382 | CMS |
| ABBVIE INC. | $4.57 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103908384 | CMS |
| ABBVIE INC. | $425.00 | 09/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103135317 | CMS |
| ABBVIE INC. | $24.57 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103908386 | CMS |
| ABBVIE INC. | $31.83 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103908388 | CMS |
| Amgen Inc. | $13.71 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111598270 | CMS |
| Amgen Inc. | $22.77 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111598274 | CMS |
| Amgen Inc. | $22.52 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111598276 | CMS |
| Amgen Inc. | $14.37 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111598272 | CMS |
| AstraZeneca Pharmaceuticals LP | $95.55 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105747133 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.69 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104248315 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.77 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104334172 | CMS |
| AstraZeneca Pharmaceuticals LP | $2.65 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105475753 | CMS |
| Aurinia Pharma U.S., Inc. | $16.05 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150681861 | CMS |
| Fresenius Kabi USA, LLC | $22.99 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146949186 | CMS |
| GENZYME CORPORATION | $22.83 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139582270 | CMS |
| Janssen Biotech, Inc. | $17.26 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078634653 | CMS |
| Janssen Biotech, Inc. | $17.64 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078632577 | CMS |
| Lilly USA, LLC | $18.69 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135091741 | CMS |
| Novartis Pharmaceuticals Corporation | $25.85 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086937099 | CMS |
| UCB, Inc. | $20.04 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143328507 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.